The retail price of Nurtec ODT (rimegepant) can vary significantly based on insurance coverage, pharmacy, and whether a discount program is utilized. Without insurance, a one-month supply of Nurtec ODT can cost approximately $1,000 to $1,200 [1].
How can I get Nurtec at a lower cost?
Several options exist to potentially reduce the out-of-pocket cost of Nurtec ODT. Patients may be eligible for manufacturer-sponsored discount programs. For instance, the Nurtec ODT Savings Card program can offer eligible commercially insured patients a savings of up to $150 per prescription [1]. Eligibility requirements for these programs typically involve having commercial prescription insurance and not being enrolled in government-funded healthcare programs like Medicare or Medicaid [1].
What is Nurtec ODT used for?
Nurtec ODT is a prescription medication approved for the acute treatment of migraine with or without aura in adults. It is also approved for the preventive treatment of episodic migraine in adults [2]. The medication works by targeting calcitonin gene-related peptide (CGRP), a molecule involved in migraine pain [2].
When does Nurtec ODT patent expire?
The patent landscape for Nurtec ODT is complex, with various patents covering its composition of matter, methods of use, and manufacturing processes. According to DrugPatentWatch.com, the earliest expected patent expiry for Nurtec ODT is in 2034 [3]. However, the effective market exclusivity period can be influenced by patent litigation and potential approval of generic alternatives [3].
What are the alternatives to Nurtec ODT for migraine treatment?
Alternatives for migraine treatment include other CGRP inhibitors, triptans, and preventive medications. Some CGRP inhibitors available include ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) for acute treatment, and erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality) for preventive treatment [4]. Triptans, such as sumatriptan, are another class of acute migraine medications [4].
What clinical trials have been conducted for Nurtec ODT?
Clinical trials for Nurtec ODT have demonstrated its efficacy in both acute and preventive treatment of migraine. Studies have shown significant pain freedom and absence of the most bothersome migraine-associated symptom at two hours post-dose for acute treatment [2]. For preventive treatment, trials have shown a reduction in monthly migraine days [2].
Sources:
1. https://www.nurtec.com/migraine-treatment-savings
2. https://www.nurtec.com/
3. https://drugpatentwatch.com/
4. https://www.mayoclinic.org/diseases-conditions/migraine-headache/diagnosis-treatment/drc-20360202